PBS Dec changes
December 4, 2012
EYLEA (aflibercept 4 mg/0.1 mL
injection, 1 x 0.1 mL vial), Myfortic
(mycophenolate 180 mg tablet:
enteric, 120 tablets), and Phebra
Naproxen Suspension (naproxen
125 mg/5 mL oral liquid, 474 mL)
are just three of the new December
additions to the Pharmaceutical
Benefits Scheme this month.
The full list now available to view
on the PBS website
(www.pbs.gov.au), and also
includes the addition of Paraffin +
Retinyl Palmitate, paraffin + retinyl
palmitate 138 microgram/g
(equivalent to 250 units/g vitamin
A) eye ointment, 5g; and Votrient
(pazopanib 200 mg tablet, 30).
Meanwhile December has also
seen a number of deletions from
the PBS, including Celestone-M,
Antroquoril (betamethasone (as
valerate) 0.02% (200 microgram/g)
ointment, 100G); and Nemdyn
(Neomycin + Bacitracin Zinc, neomycin
3.5mg/g + bacitracin zinc 400
international units/g ointment, 10g).
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 12